You are here

Sanofi

Sanofi opens doors to $130M 'flagship' US office facility in New Jersey

Fierce Pharma

Thu, 05/22/25 - 09:22 pm

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Fierce Biotech

Thu, 05/22/25 - 11:42 am

Vigil Neuroscience

Alzheimer's disease

Zentiva inks €220M deal to commercialize AstraZeneca GI cast-off in Europe

Fierce Pharma

Thu, 05/22/25 - 11:10 am

linaprazan glurate

Sanofi hops on the US investment bandwagon with $20B commitment through 2030

Fierce Pharma

Wed, 05/14/25 - 10:52 pm

drug manufacturing

Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures

Fierce Biotech

Fri, 05/9/25 - 08:28 am

IGM Biosciences

Sanofi exec tells biotechs not to scrimp on clinical trial design

Clinical Trials Arena

Thu, 05/8/25 - 10:47 pm

clinical trials

clinical trial design

Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals

Fierce Pharma

Wed, 04/30/25 - 11:47 pm

consumer health

Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged

MSN Reuters

Thu, 04/24/25 - 11:01 am

Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot

Fierce Biotech

Wed, 04/23/25 - 09:47 am

natural killer cells

Sanofi, Regeneron win FDA nod for Dupixent in chronic hives

BioPharma Dive

Mon, 04/21/25 - 11:13 am

Sanofi pens $1.8B research deal for 2 bispecific antibodies aimed at autoimmune, immunology

Fierce Biotech

Thu, 04/17/25 - 11:08 am

bispecific antibodies

ulcerative colitis

Crohn’s disease

Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma

Pharmaphorum

Tue, 04/15/25 - 09:53 am

clinical trials

AAN 2025: Sanofi’s tolebrutinib likely to be first BTK inhibitor for the treatment of MS

Clinical Trials Arena

Wed, 04/9/25 - 10:58 pm

multiple sclerosis

The top 10 pharma R&D budgets for 2024

Fierce Biotech

Fri, 04/4/25 - 11:30 am

Bristol Myers Squibb

Sanofi taps Nurix for pipeline nourishment once again, picking up autoimmune degrader for $15M

Fierce Biotech

Wed, 04/2/25 - 11:40 am

Nurix Therapeutics

autoimmune diseases

protein degradation

FDA approves first-of-its-kind RNA drug for hemophilia

BioPharma Dive

Sun, 03/30/25 - 10:26 pm

FDA fast-tracks Sanofi's experimental chlamydia vaccine

Pharmaphorum

Thu, 03/27/25 - 11:05 am

FDA starts review of Sanofi's MS hope tolebrutinib

Pharmaphorum

Tue, 03/25/25 - 10:20 am

multiple sclerosis

Sanofi to acquire Dren Bio’s immunology unit

Investing.com

Thu, 03/20/25 - 11:25 am

autoimmune diseases

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program

Fierce Pharma

Tue, 03/18/25 - 11:00 pm

Teva Pharmaceutical

Inflation Reduction Act

Pages